Why the study?
Does convalescent serum therapy reduce mortality and paralysis in patients with acute poliomyelitis?
Population
Patients with acute poliomyelitis, including the preparalytic form
Design
Review
Authors
Loading...
May support convalescent serum in preparalytic polio; hypothesis-generating from Level 5 data, controlled trials needed.
Does convalescent serum therapy reduce mortality and paralysis in patients with acute poliomyelitis?
Early literature suggests convalescent serum therapy may reduce mortality and paralysis in acute poliomyelitis.
Paul H. Harmon (1934) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: